In silico analysis of the transcriptome of human breast tumors confirmed the association between RANK expression and stem cell and mesenchymal markers in ER+/HER2– tumors, leading to the hypothesis that luminal RANK-positive cells may constitute an important reservoir of slow cycling, therapy-resistant cancer cells [124]. Here, ESR1 is linked to breast neoplasm.